Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neoadjuvant chemotherapy in breast cancer: a dose-dense schedule in real life and putative role of PIK3CA mutations.
Cocciolone V, Cannita K, Tessitore A, Mastroiaco V, Rinaldi L, Paradisi S, Irelli A, Baldi PL, Sidoni T, Ricevuto E, Dal Mas A, Calvisi G, Coletti G, Ciccozzi A, Pizzorno L, Resta V, Bafile A, Alesse E, Ficorella C. Cocciolone V, et al. Among authors: calvisi g. Oncotarget. 2018 Jun 8;9(44):27380-27396. doi: 10.18632/oncotarget.25270. eCollection 2018 Jun 8. Oncotarget. 2018. PMID: 29937992 Free PMC article.
Weekly alternate intensive regimen FIrB/FOx in metastatic colorectal cancer patients: an update from clinical practice.
Cortellini A, Cannita K, Parisi A, Lanfiuti Baldi P, Venditti O, D'Orazio C, Dal Mas A, Calvisi G, Giordano AV, Vicentini V, Vicentini R, Felicioni L, Marchetti A, Buttitta F, Russo A, Ficorella C. Cortellini A, et al. Among authors: calvisi g. Onco Targets Ther. 2019 Mar 25;12:2159-2170. doi: 10.2147/OTT.S194745. eCollection 2019. Onco Targets Ther. 2019. PMID: 30988620 Free PMC article.
Anthracycline-Free Neoadjuvant Treatment in Patients with HER2-Positive Breast Cancer: Real-Life Use of Pertuzumab, Trastuzumab and Taxanes Association with an Exploratory Analysis of PIK3CA Mutational Status.
Irelli A, Parisi A, D'Orazio C, Sidoni T, Rotondaro S, Patruno L, Pavese F, Bafile A, Resta V, Pizzorno L, Ciuffetelli V, Dal Mas A, Calvisi G, Di Sibio A, Marzullo A, Zelli V, Compagnoni C, Tessitore A, Alesse E, Ficorella C, Cortellini A, Cannita K. Irelli A, et al. Among authors: calvisi g. Cancers (Basel). 2022 Jun 18;14(12):3003. doi: 10.3390/cancers14123003. Cancers (Basel). 2022. PMID: 35740668 Free PMC article.
Intensive first-line FIr-C/FOx-C association of triplet chemotherapy plus cetuximab in RAS wild-type metastatic colorectal cancer patients: preliminary phase II data and prediction of individual limiting toxicity syndromes by pharmacogenomic biomarkers.
Bruera G, Massacese S, Pepe F, Malapelle U, Dal Mas A, Ciacco E, Calvisi G, Troncone G, Simmaco M, Ricevuto E. Bruera G, et al. Among authors: calvisi g. Ther Adv Med Oncol. 2019 May 10;11:1758835919846421. doi: 10.1177/1758835919846421. eCollection 2019. Ther Adv Med Oncol. 2019. PMID: 31205502 Free PMC article.
Systemic sclerosis associated with colliquative necrosis in the cerebellum.
Ricci A, Di Vitantonio H, De Paulis D, Del Maestro M, Dehcordi SR, Murrone D, Coletti G, Calvisi G, Galzio RJ. Ricci A, et al. Among authors: calvisi g. Surg Neurol Int. 2017 Apr 5;8:44. doi: 10.4103/sni.sni_401_16. eCollection 2017. Surg Neurol Int. 2017. PMID: 28480106 Free PMC article.
Brain location and tumor biological markers in high- and low-grade gliomas.
Raysi Dehcordi S, Galzio R, Marrone F, DI Vitantonio H, Marzi S, Fasano T, Taddei G, Millimaggi D, DI Cosimo T, Abbate F, Calvisi G, Masciocchi C, Ricci A. Raysi Dehcordi S, et al. Among authors: calvisi g. J Neurosurg Sci. 2023 Apr;67(2):143-149. doi: 10.23736/S0390-5616.20.05047-X. Epub 2020 Dec 15. J Neurosurg Sci. 2023. PMID: 33320464
Dose-finding study of intensive weekly alternating schedule of docetaxel, 5-fluorouracil, and oxaliplatin, FD/FOx regimen, in metastatic gastric cancer.
Bruera G, Massacese S, Galvano A, Mas AD, Guadagni S, Calvisi G, Ciacco E, Russo A, Ricevuto E; Oncology Network ASL1 Abruzzo, Italy. Bruera G, et al. Among authors: calvisi g. Oncotarget. 2018 Apr 17;9(29):20339-20350. doi: 10.18632/oncotarget.24861. eCollection 2018 Apr 17. Oncotarget. 2018. PMID: 29755655 Free PMC article.
41 results